Faecal occult blood test as a screening test for colorectal cancer

Acta Gastro-Enterologica Belgica

Volumn 68, Issue 2, 2005, Pages 244-246

  Janssens, J F ^a  

^a Sint Elisabethziekenhuis Turnhout   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXIDASE;

CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; CONFERENCE PAPER; CONSENSUS; CONTRAST RADIOGRAPHY; FOLLOW UP; GENERAL PRACTITIONER; GUAIAC TEST; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH EDUCATION; HEALTH PRACTITIONER; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; META ANALYSIS; OCCULT BLOOD TEST; PATIENT COMPLIANCE; PREDICTION; RESOURCE ALLOCATION; RISK FACTOR; SAMPLING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY; SYSTEMATIC REVIEW;

ADULT; AGE DISTRIBUTION; AGED; BELGIUM; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 21844442624     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Faivre J. Screening for colorectal cancer with fecal occult blood tests: trial evidence and beyond. Acta Gastroenterol Belg 2005, 68: S03.
2. Faivre J, Dancourt V, Lejeune C, Tazi MA, Lamour J, Gerard D, Dassonville F, Bonithon-Kopp C. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004; 126: 1674-1680.
3. nd ed. Blackwell Publishing 2004: 255-257.
4. Hawk ET and Levin B. Colorectal cancer prevention. J Clin Oncol 2005; 23: 378-391.
5. Allison JE. Screening for colorectal cancer 2003: is there still a role for the FOBT? Techniques in Gastrointestinal Endoscopy 2003; 5: 127-133.
6. Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening colorectal cancer. CA Cancer J Clin 2003; 53: 44-55.
7. Brommer M, Weinberg D. Screening for colorectal cancer-now and near future. Semin Oncol 2005; 32: 3-10.
8. Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, Ransohoff DF. A national survey of primary care physicians' methods for screening for fecal occult blood. Ann Intern Med 2005; 142: 86-94.
9. Sox HC. Office-bases testing for fecal occult blood: do only in case of emergency. Ann Intern Med 2005; 142: 146-147.
10. Young G, James D, Winawer S. Choice of fecal blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies. A WHO and OMED report. Am J Gastroenterol 2002; 97: 2499-2507.
11. Collins JF, Lieberman DA, Durbin TE, Weiss DG. Veterans Affairs Cooperative Study #380 Group. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination. Ann Intern Med 2005; 142: 81-85.
12. Saito H. Screening for colorectal cancer by immunochemical fecal occult blood testing. Jpn J Cancer Res 1996; 87: 1011-1024.
13. Crotta S, Castiglione G, Grazzini G, Valle F, Mosconi S, Rosset R. Feasibility study of colorectal cancer screening by immunochemical faecal blood testing: results in a northern Italian community. Eur J Gastroenterol Hepatol 2004; 16: 33-37.
14. Nakajima M, Saito H, Soma Y, Sobue T, Tanaka M, Munakala A. Prevention of advanced colorectal cancer by screening using the immunochemical fecal occult blood test: a case-control study. Br J Cancer 2003; 89: 23-28.
15. Grazzini G, Castiglione G, Franceschini F et al. Colorectal cancer screening programme by fecal occult blood testing in Tuscany: first round results. Eur J Cancer Prev 2004; 13: 19-26.
16. Colin JF, Vanheuverzwyn R. Colorectal cancer screening. Acta Gastroenterol Belg 2001, 64: 255-257.
17. Buset M. Primary prevention of colorectal cancer. Acta Gastroenterol Belg 2003, 66: 20-21.